Summary: In a small randomised study in Hashimoto’s thyroiditis, six months of dietary management reduced quantitative thyroid MRI markers of inflammation and lowered TPO and thyroglobulin antibodies, while an untreated control group showed no change.
PICO Summary
| Element | Detail |
|---|---|
| Population | 40 patients with Hashimoto’s thyroiditis, randomised evenly to intervention or control. |
| Intervention | 6 months of dietary management, with laboratory and multiparametric MRI assessment at baseline and 6 months. |
| Comparison | No intervention. |
| Outcome | Intervention group: thyroid T2WI relative signal intensity fell 1.69→1.42 (p<0.05) and water fraction 94.57→93.36 (p<0.001); TPOAb 376.58→273.55 and TGAb 219.06→198.80 (both p<0.05). No significant change in controls. TSH/T4 outcomes not reported. |
MRI-Tracked Diet in Hashimoto's
RCT · Hashimoto's thyroiditis · 6 months
Six months of (unspecified) dietary management lowered quantitative thyroid MRI inflammation markers and TPO/Tg antibodies versus no change in controls. Hypothesis-generating: the diet is undefined and no thyroid-function endpoints were reported.
Expert Commentary
The genuinely interesting idea here is methodological: using quantitative multiparametric MRI to see thyroid tissue inflammation directly, rather than inferring it from antibody titres that fluctuate unreliably. That imaging markers and antibodies moved together after dietary management is a coherent signal, and concordant changes across independent measures are harder to dismiss as noise. My enthusiasm stops well short of clinical recommendation, for one overriding reason the paper cannot escape: the dietary intervention is never specified. Without knowing whether this was gluten elimination, selenium, an anti-inflammatory pattern, or something else, the result is impossible to reproduce or prescribe, it tells us diet can move these markers, not which diet to use. Add a small sample of forty, no reported thyroid-function outcomes, and no evidence that the MRI changes translate into slower progression or lower levothyroxine needs, and this stays firmly hypothesis-generating. Can I use this with my patients? Only in the conversation I already have, that levothyroxine treats the hormone deficiency while reasonable, evidence-based dietary measures such as selenium or gluten reduction in those with sensitivity may modestly reduce autoimmune activity, tracked by antibodies. I would want a defined, randomised dietary protocol with functional endpoints before saying more.
References
Dai N, Shi QH, Zheng LW, Huang XS, Fan SF. Quantitative multi-parameter MRI evaluation of Hashimoto’s thyroiditis changes after dietary interventions. Med Sci Monit. 2025;31:e947862. doi:10.12659/MSM.947862